(Reuters) – Germany’s largest drugmaker Bayer said it agreed to buy privately held Steigerwald Arzneimittelwerk GmbH, a maker of herbal treatments.
Bayer said on Thursday that Steigerwald, based in Darmstadt, Germany, generated sales of 61.3 million euros ($78.8 million) in 2012 with 180 staff. It did not disclose financial terms of the takeover.
($1 = 0.7775 euros)
(Reporting by Ludwig Burger)
